151 related articles for article (PubMed ID: 27578443)
1. Retrospective analysis of vancomycin treatment outcomes in Chinese paediatric patients with suspected Gram-positive infection.
Wei WX; Qin XL; Cheng DH; Lu H; Liu TT
J Clin Pharm Ther; 2016 Dec; 41(6):650-656. PubMed ID: 27578443
[TBL] [Abstract][Full Text] [Related]
2. Relationship between initial vancomycin concentration-time profile and nephrotoxicity among hospitalized patients.
Lodise TP; Patel N; Lomaestro BM; Rodvold KA; Drusano GL
Clin Infect Dis; 2009 Aug; 49(4):507-14. PubMed ID: 19586413
[TBL] [Abstract][Full Text] [Related]
3. Incidence of nephrotoxicity and association with vancomycin use in intensive care unit patients with pneumonia: retrospective analysis of the IMPACT-HAP Database.
Cano EL; Haque NZ; Welch VL; Cely CM; Peyrani P; Scerpella EG; Ford KD; Zervos MJ; Ramirez JA; Kett DH;
Clin Ther; 2012 Jan; 34(1):149-57. PubMed ID: 22284995
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of Vancomycin on Gram-Positive Bacterial Infection in Elderly Critical Patients and Risk Factors Associated With Nephrotoxicity.
Huang M; Wu H; Zhou J; Xu M; Zhou S
Arch Iran Med; 2018 Aug; 21(8):349-355. PubMed ID: 30113856
[TBL] [Abstract][Full Text] [Related]
5. Vancomycin efficiency and safety of a dosage of 40-60 mg/kg/d and corresponding trough concentrations in children with Gram-positive bacterial sepsis.
Peng L; Guo Z; Zhang G; Tian X; Gu R; Li Q; Li Y; Luo Z
Front Cell Infect Microbiol; 2023; 13():1117717. PubMed ID: 37065209
[TBL] [Abstract][Full Text] [Related]
6. Pharmacodynamic Characteristics of Nephrotoxicity Associated With Vancomycin Use in Children.
Le J; Ny P; Capparelli E; Lane J; Ngu B; Muus R; Romanowski G; Vo T; Bradley J
J Pediatric Infect Dis Soc; 2015 Dec; 4(4):e109-16. PubMed ID: 26582878
[TBL] [Abstract][Full Text] [Related]
7. Systematic review and meta-analysis to explore optimal therapeutic range of vancomycin trough level for infected paediatric patients with Gram-positive pathogens to reduce mortality and nephrotoxicity risk.
Kato H; Hagihara M; Okudaira M; Asai N; Koizumi Y; Yamagishi Y; Mikamo H
Int J Antimicrob Agents; 2021 Aug; 58(2):106393. PubMed ID: 34174409
[TBL] [Abstract][Full Text] [Related]
8. Vancomycin serum trough concentration vs. clinical outcome in patients with gram-positive infection: a retrospective analysis.
Cao G; Liang X; Zhang J; Zhou Y; Wu J; Zhang Y; Chen Y; Huang J; Liu X; Yu J
J Clin Pharm Ther; 2015 Dec; 40(6):640-4. PubMed ID: 26383121
[TBL] [Abstract][Full Text] [Related]
9. Relationship between vancomycin trough concentrations and nephrotoxicity: a prospective multicenter trial.
Bosso JA; Nappi J; Rudisill C; Wellein M; Bookstaver PB; Swindler J; Mauldin PD
Antimicrob Agents Chemother; 2011 Dec; 55(12):5475-9. PubMed ID: 21947388
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of risk factors for vancomycin-induced nephrotoxicity.
Park SJ; Lim NR; Park HJ; Yang JW; Kim MJ; Kim K; In YW; Lee YM
Int J Clin Pharm; 2018 Oct; 40(5):1328-1334. PubMed ID: 29744794
[TBL] [Abstract][Full Text] [Related]
11. Clinical outcomes and nephrotoxicity associated with vancomycin trough concentrations during treatment of deep-seated infections.
Hermsen ED; Hanson M; Sankaranarayanan J; Stoner JA; Florescu MC; Rupp ME
Expert Opin Drug Saf; 2010 Jan; 9(1):9-14. PubMed ID: 20021290
[TBL] [Abstract][Full Text] [Related]
12. Association of Initial Trough Concentrations of Vancomycin with Outcomes in Pediatric Patients with Gram-Positive Bacterial Infection.
Kondo M; Nakagawa S; Orii S; Itohara K; Sugimoto M; Omura T; Sato Y; Imai S; Yonezawa A; Nakagawa T; Matsubara K
Biol Pharm Bull; 2020; 43(10):1463-1468. PubMed ID: 32999156
[TBL] [Abstract][Full Text] [Related]
13. The Relationship of nephrotoxicity to vancomycin trough serum concentrations in a veteran's population: a retrospective analysis.
Horey A; Mergenhagen KA; Mattappallil A
Ann Pharmacother; 2012 Nov; 46(11):1477-83. PubMed ID: 23073306
[TBL] [Abstract][Full Text] [Related]
14. Factors associated with development of nephrotoxicity in patients treated with vancomycin versus daptomycin for severe Gram-positive infections: A practice-based study.
Barberan J; Mensa J; Artero A; Epelde F; Rodriguez JC; Ruiz-Morales J; Calleja JL; Guerra JM; Martínez-Gil I; Giménez MJ; Granizo JJ; Aguilar L
Rev Esp Quimioter; 2019 Feb; 32(1):22-30. PubMed ID: 30630306
[TBL] [Abstract][Full Text] [Related]
15. Outcomes and Nephrotoxicity Associated with Vancomycin Treatment in Patients 80 Years and Older.
Wang Y; Dai N; Wei W; Jiang C
Clin Interv Aging; 2021; 16():1023-1035. PubMed ID: 34103905
[TBL] [Abstract][Full Text] [Related]
16. Vancomycin-associated nephrotoxicity in non-critically ill patients admitted in a Brazilian public hospital: A prospective cohort study.
de Almeida CDC; Simões E Silva AC; de Queiroz Oliveira JA; Batista ISF; Pereira FH; Gonçalves JE; Nobre V; Martins MAP
PLoS One; 2019; 14(9):e0222095. PubMed ID: 31487314
[TBL] [Abstract][Full Text] [Related]
17. Incidence and predictors of vancomycin-associated nephrotoxicity.
Moh'd H; Kheir F; Kong L; Du P; Farag H; Mohamad A; Zurlo JJ
South Med J; 2014 Jun; 107(6):383-8. PubMed ID: 24945176
[TBL] [Abstract][Full Text] [Related]
18. High versus low vancomycin serum trough regimen for Gram-positive infections: a meta-analysis.
Meng L; Fang Y; Chen Y; Zhu H; Long R
J Chemother; 2015 Aug; 27(4):213-20. PubMed ID: 24641266
[TBL] [Abstract][Full Text] [Related]
19. Reduced nephrotoxicity with vancomycin therapeutic drug monitoring guided by area under the concentration-time curve against a trough 15-20 μg/mL concentration.
Oda K; Jono H; Nosaka K; Saito H
Int J Antimicrob Agents; 2020 Oct; 56(4):106109. PubMed ID: 32721597
[TBL] [Abstract][Full Text] [Related]
20. Association of vancomycin serum concentrations with outcomes in patients with gram-positive bacteremia.
Zimmermann AE; Katona BG; Plaisance KI
Pharmacotherapy; 1995; 15(1):85-91. PubMed ID: 7739950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
